Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -43.75% is 77% above its 5-year average of -189.57%, around the middle of its 5-year range (-943.64%–383.53%).
85.56% above its 12-month average of -302.93%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 65.72%.
OPERATING MARGIN
-43.75%
OPERATING MARGIN AVG TTM
-302.93%
OPERATING MARGIN AVG 3Y
-147.49%
OPERATING MARGIN AVG 5Y
-189.57%
OPERATING MARGIN AVG 10Y
-288.99%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+85.56%
CURRENT VS 3Y AVG
+70.34%
CURRENT VS 5Y AVG
+76.92%
CURRENT VS 10Y AVG
+84.86%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Arvinas, Inc.
Market Cap
$471.65M
Operating Margin
-43.75%
TTM Avg
-302.93%
3Y Avg
-147.49%
5Y Avg
-189.57%
Market Cap
$471.57M
Operating Margin
-0.73%
TTM Avg
-6.05%
3Y Avg
-13.09%
5Y Avg
-25.54%
Market Cap
$472.23M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$469.12M
Operating Margin
-36.19%
TTM Avg
-55.58%
3Y Avg
-82.00%
5Y Avg
-57.61%
Market Cap
$475.91M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-8.04%
5Y Avg
-6.43%
Market Cap
$465.75M
Operating Margin
-47.95%
TTM Avg
-55.61%
3Y Avg
-74.90%
5Y Avg
-86.86%
Market Cap
$483.54M
Operating Margin
13.16%
TTM Avg
14.88%
3Y Avg
13.50%
5Y Avg
6.84%
Market Cap
$486.01M
Operating Margin
-7.33%
TTM Avg
-12.79%
3Y Avg
-23.47%
5Y Avg
-68.20%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arvinas, Inc. (ARVN) | $471.65M | -43.75% | -302.93% | -147.49% | -189.57% |
| Cerus Corporation (CERS)vs › | $471.57M | -0.73% | -6.05% | -13.09% | -25.54% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.23M | 0.00% | 0.00% | 0.00% | 0.00% |
| Alpha Teknova, Inc. (TKNO)vs › | $469.12M | -36.19% | -55.58% | -82.00% | -57.61% |
| Kamada Ltd. (KMDA)vs › | $467.90M | 14.51% | 13.50% | 9.39% | 8.55% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $475.91M | 0.00% | 0.00% | -8.04% | -6.43% |
| Sight Sciences, Inc. (SGHT)vs › | $465.75M | -47.95% | -55.61% | -74.90% | -86.86% |
| Puma Biotechnology, Inc. (PBYI)vs › | $483.54M | 13.16% | 14.88% | 13.50% | 6.84% |
| Evolus, Inc. (EOLS)vs › | $486.01M | -7.33% | -12.79% | -23.47% | -68.20% |
| NRC Health (NRC)vs › | $452.54M | 10.53% | 20.52% | 24.67% | 27.45% |
Gross Margin
96.4%
Operating Margin
-43.8%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 65.72% |
| 2026-03-31 | -401.92% |
| 2025-12-31 | -754.74% |
| 2025-09-30 | -104.53% |
| 2025-06-30 | -319.20% |
| 2025-03-31 | 37.82% |
| 2024-12-31 | -98.31% |
| 2024-09-30 | -58.89% |
| 2024-06-30 | -63.40% |
| 2024-03-31 | -329.25% |
| 2023-12-31 | 383.53% |
| 2023-09-30 | -213.58% |
| 2023-06-30 | -136.88% |
| 2023-03-31 | -269.85% |
| 2022-12-31 | -198.42% |
| 2022-09-30 | -193.67% |
| 2022-06-30 | -194.67% |
| 2022-03-31 | -217.74% |
| 2021-12-31 | -206.84% |
| 2021-09-30 | -508.60% |
| 2021-06-30 | -943.64% |
| 2021-03-31 | -758.18% |
| 2020-12-31 | -1948.58% |
| 2020-09-30 | -417.92% |
| 2020-06-30 | -460.78% |
| 2020-03-31 | -375.22% |
| 2019-12-31 | -465.74% |
| 2019-09-30 | 18.32% |
| 2019-06-30 | -458.73% |
| 2019-03-31 | -393.74% |
| 2018-12-31 | -492.52% |
| 2018-09-30 | -416.53% |
| 2018-06-30 | -250.52% |
| 2018-03-31 | -104.22% |
| 2017-12-31 | -206.31% |
| 2017-09-30 | -384.17% |
| 2017-06-30 | -402.95% |
| 2017-03-31 | -378.53% |
